Oncolytics Biotech releases REOLYSIN phase I clinical trial results.
D017321:Clinical Trials, Phase I as Topic / Q000706:statistics & numerical data; D004345:Drug Industry / Q000706:statistics & numerical data; D006801:Humans; D012190:Retroviridae / Q000187:drug effects; D016896:Treatment Outcome; D018631:ras Proteins / Q000009:adverse effects / Q000627:therapeutic use*
D018631:ras Proteins